In 2020, market access rebates and discounts as a subcomponent of gross expenditures for brand medicines accounted for more than 102 billion U.S. dollars in the United States. The statistic illustrates the total market access rebates and discounts for brand medicines by components from 2013 to 2020, by component.
Market access rebates and discounts for brand medicines in the U.S. from 2013 to 2020, by component
(in billion U.S. dollars)
Characteristic
Negotiated health plan and PBM rebates and fees
Patient cost sharing assistance
2020
102.1
13.9
2019
93.1
12.9
2018
81.9
12.9
2017
67.4
10.6
2016
59
8.7
2015
54.9
6.9
2014
42.1
5.4
2013
31.2
4.2
Created with Highcharts 7.2.2Payments in billion U.S. dollars31.231.242.142.154.954.9595967.467.481.981.993.193.1102.1102.14.24.25.45.46.96.98.78.710.610.612.912.912.912.913.913.9Negotiated health plan and PBM rebates and feesPatient cost sharing assistance20132014201520162017201820192020
0255075100125
Add this content to your personal favorites. These can be accessed from the favorites menu in the main navigation.
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
Learn more about how Statista can support your business.
BRG. (January 31, 2022). Market access rebates and discounts for brand medicines in the U.S. from 2013 to 2020, by component (in billion U.S. dollars) [Graph]. In Statista. Retrieved April 08, 2025, from https://www.statista.com/statistics/1100622/market-access-rebates-and-discounts-for-brand-medicines-by-component-in-the-us/
BRG. "Market access rebates and discounts for brand medicines in the U.S. from 2013 to 2020, by component (in billion U.S. dollars)." Chart. January 31, 2022. Statista. Accessed April 08, 2025. https://www.statista.com/statistics/1100622/market-access-rebates-and-discounts-for-brand-medicines-by-component-in-the-us/
BRG. (2022). Market access rebates and discounts for brand medicines in the U.S. from 2013 to 2020, by component (in billion U.S. dollars). Statista. Statista Inc.. Accessed: April 08, 2025. https://www.statista.com/statistics/1100622/market-access-rebates-and-discounts-for-brand-medicines-by-component-in-the-us/
BRG. "Market Access Rebates and Discounts for Brand Medicines in The U.S. from 2013 to 2020, by Component (in Billion U.S. Dollars)." Statista, Statista Inc., 31 Jan 2022, https://www.statista.com/statistics/1100622/market-access-rebates-and-discounts-for-brand-medicines-by-component-in-the-us/
BRG, Market access rebates and discounts for brand medicines in the U.S. from 2013 to 2020, by component (in billion U.S. dollars) Statista, https://www.statista.com/statistics/1100622/market-access-rebates-and-discounts-for-brand-medicines-by-component-in-the-us/ (last visited April 08, 2025)
Market access rebates and discounts for brand medicines in the U.S. from 2013 to 2020, by component (in billion U.S. dollars) [Graph], BRG, January 31, 2022. [Online]. Available: https://www.statista.com/statistics/1100622/market-access-rebates-and-discounts-for-brand-medicines-by-component-in-the-us/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.